Neil H. Bander

Mutations of the VHL tumour suppressor gene in renal carcinoma

James R. Gnarra, Kálmán Tory, Y Weng et al. · Nature Genetics · 1994 · 1.7K citations

Medicine, Genetics, Molecular Genetics +14

Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile

Jeffrey S. Hrkach, Daniel D. Von Hoff, Mir Mukkaram Ali et al. · Science Translational Medicine · 2012 · 1.1K citations

Pharmacy, Pharmaceutics, Pharmacology +17

Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature.

Sam S. Chang, Victor E. Reuter, W. D. W. Heston et al. · PubMed · 1999 · 814 citations

Medicine, Cell Biology, Oncology +17

Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse

Cora N. Sternberg, Alan Yagoda, Howard I. Scher et al. · Cancer · 1989 · 673 citations

Medicine, Oncology, Pharmacotherapy +14

The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer

Dimple Chakravarty, Andrea Sboner, Sujit S. Nair et al. · Nature Communications · 2014 · 630 citations · Full text

Medicine, Molecular Biology, Oncology +17